[1] WINGERCHUK DM, Banwell B, Bennett JL, et al.International consensus diagnostic criteria for neuromyelitisoptica spectrum disorders[J].Neurology, 2015, 85(2):177. doi: 10.1212/WNL.0000000000001729
[2] HARRINGTON LE, HATTONRD, MANGAN PR, et al.Interleukin 17-pro-ducing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol, 2005, 6(11):1123. doi: 10.1038/ni1254
[3] ISAILOVIC N, DAIGO K, MANTOVANI A.Interleukin-17 and innate immunity in infections and chronic inflammation[J].J Autoimmunity, 2015, 60:1. doi: 10.1016/j.jaut.2015.04.006
[4] KUWABARA T, ISHIKAWA F, KONDO M.The role of IL-17 and related cytokines in inflammatory autoimmune diseases[J].Med Inflammation, 2017, 2017:3908061
[5] LI YF, ZHANG SX, MA XW, et al.Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with multiple sclerosis:A meta-analysis[J].Mult Scler Relat Disord, 2017, 18:20. doi: 10.1016/j.msard.2017.09.003
[6] KOMIYAMA Y, NAKAE S, MATSUKI T, et al.IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis[J].J Immunol, 2006, 177(1):566.
[7] KALINKE U, PRINZ M.Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS[J].Immunol Cell Biol, 2012, 90(5):505. doi: 10.1038/icb.2012.8
[8] WANG X, MA C, WU J, et al.Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models[J].J Neurosci Res, 2013, 91(7):871. doi: 10.1002/jnr.23233
[9] UZAWA A, MORI M, KUWABARA S.Cytokines and chemokines in neuromyelitisoptica:pathogenetic and therapeutic implications[J].Brain Pathol, 2014, 24(1):67. doi: 10.1111/bpa.12097
[10] WANG HH, DAI YQ, QIU W, et al.Interleukin-17-secreting T cells in neuromyelitisoptica and multiple sclerosis during relapse[J].J Clin Neurosci, 2011, 18(10):1313. doi: 10.1016/j.jocn.2011.01.031
[11] VARRIN-DOYER M, SPENCER CM, SCHULZE-TOPPHOFF U, et al.Aquaporin 4-specific T cells in neuromyelitisoptica exhibit a Th17 bias and recognize Clostridium ABC transporter[J].Ann Neurol, 2012, 72(1):53. doi: 10.1002/ana.23651
[12] MELINA VJ, HWA H, PETER AC, et al.Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitisoptica[J].Acta Neuropathol Commun, 2015, 3(1):28. doi: 10.1186/s40478-015-0207-1
[13] WANG H, ZHONG X, WANG K, et al.Interleukin 17 gene polymorphism is associated with anti-aquaporin 4 antibody-positive neuromyelitisoptica in the Southern Han Chinese——a case control study[J].J Neurol Sci, 2012, 314(1/2):26.
[14] MATIELLO M, JACOB A, WINGERCHUK DM, et al.Neuromyelitisoptica[J].Curr Opin Neurol, 2007, 20(3):255. doi: 10.1097/WCO.0b013e32814f1c6b
[15] WINGERCHUK DM, WEINSHKER BG.The emerging relationship between neuromyelitisoptica and systemic rheumatoligicautommune disease[J].Mult Seler, 2012, 18(1):5.
[16] LI Y, WANG HH, LONG YM, et al.Increased memory Th17 cells inpatients with neuromyelitis optica and multiple sclerosis[J].J Neuroimmunol, 2011, 234(1/2):155.
[17] 许娟娟, 许力, 李云云, 等.视神经脊髓炎谱系病病人血清AQP4-IgG水平及其临床意义[J].蚌埠医学院学报, 2017, 42(7):861.
[18] 彭丽君, 钱海蓉, 毛琳玲, 等.神经丝蛋白轻链在视神经脊髓炎谱系疾病诊断和预后中的意义[J].中华神经科杂志, 2017, 50(6):430. doi: 10.3760/cma.j.issn.1006-7876.2017.06.006
[19] 邱伟, 胡学强.视神经脊髓炎抗水通道蛋白4抗体再认识[J].中华神经科杂志, 2014, 47(10):673. doi: 10.3760/cma.j.issn.1006-7876.2014.10.001
[20] 郝慧琴, 张少然, 李小峰, 等.外周血Th17细胞及Treg细胞检测对系统性红斑狼疮病情的评估价值[J].中国实用内科杂志, 2018, 38(3):242.